ViroPharma Drops After Transplant Drug Fails in Study - Bloomberg PDF Print

9 (Bloomberg) -- ViroPharma Inc. lost more than half its value after its experimental drug maribavir for patients receiving bone-marrow transplants failed ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.